Search results for "NeuroD"

showing 10 items of 604 documents

Papel de la mitocondria en la neurodegeneración de las neuropatías periféricas

2014

La disfunción mitocondrial tiene severas consecuencias a nivel celular, y está íntimamente relacionada con el proceso de envejecimiento. Pero además, la mitocondria juega un importante papel en la muerte celular progresiva característica de algunos trastornos neurodegenerativos, de forma que la disfunción mitocondrial ha surgido como un denominador común en varias enfermedades neurodegenerativas. En la presente Tesis Doctoral nos hemos centrado en el estudio de los mecanismos patogénicos que conducen a la degeneración neuronal de dos neuropatías periféricas diferentes, pero relacionadas: ataxia de Friedreich (FRDA) y la enfermedad de Charcot-Marie-Tooth (CMT) tipos 4A/2K. Ambas enfermedades…

mitocondria:CIENCIAS DE LA VIDA::Genética [UNESCO]frataxinaapoptosisUNESCO::CIENCIAS DE LA VIDA::Biología celular::Cultivo celularUNESCO::CIENCIAS DE LA VIDA::Biología celularUNESCO::CIENCIAS DE LA VIDA::Neurociencias::Neurofisiología:CIENCIAS DE LA VIDA::Neurociencias::Neurofisiología [UNESCO]UNESCO::CIENCIAS DE LA VIDA::Genética:CIENCIAS DE LA VIDA::Biología celular [UNESCO]:CIENCIAS DE LA VIDA::Biología celular::Cultivo celular [UNESCO]calciogdap1estrés oxidativoestrés de retículo endoplasmáticoneuropatía periféricasenescencianeurodegeneraciónautofagia
researchProduct

The molecular anatomy of human Hsp60 and its effects on Amyloid-β peptide

Heat Shock Protein 60 (HSP60) is ubiquitous and highly conserved, being present in eukaryotes and prokaryotes, including pathogens. This chaperonin is typically considered a mitochondrial protein but it is also found in other intracellular sites, extracellularly and in circulation. HSP60 is an indispensable component of the Chaperoning System and plays a key role in protein quality control, preventing off-pathway folding events and refolding misfolded proteins. This makes HSP60 a putative therapeutic agent for neurodegenerative diseases associated with aggregation of misfolded proteins, for example, Alzheimer’s Disease. We produced and purified recombinant human HSP60 and investigated the e…

molecular chaperones Heat Shock Protein 60kDa neurodegenerative diseaseSettore BIO/16 - Anatomia Umana
researchProduct

Development of a Scoring System to Evaluate the Severity of Craniocervical Spinal Cord Compression in Patients with Mucopolysaccharidosis IVA (Morqui…

2012

BackgroundAs spinal cord compression at the craniocervical junction (CCJ) is a life-threatening manifestation in patients with mucopolysaccharidosis (MPS) IVA, surgical decompression should be performed before damage becomes irreversible. We evaluated the diagnostic value of several examinations for determining the need for decompression surgery.MethodsWe retrospectively analysed results of clinical neurological examination, somatosensory evoked potential (SEP) and magnetic resonance imaging (MRI) in 28 MPS IVA patients. A scoring system - based on the severity of findings - was used to compare results of patients with and without indication for decompression surgery. Individual test scores…

musculoskeletal diseasesmedicine.medical_specialtyScoring systembusiness.industryMucopolysaccharidosisNeurosciencesMorquio A syndromeCraniocervical junctionNeurodegenerativemedicine.diseaseMedian nerveArticleSurgerySpinal cord compressionDecompressive surgerymedicineIn patientSpinal Cord InjurybusinessJIMD reports
researchProduct

Stick around: Cell–Cell Adhesion Molecules during Neocortical Development

2021

The neocortex is an exquisitely organized structure achieved through complex cellular processes from the generation of neural cells to their integration into cortical circuits after complex migration processes. During this long journey, neural cells need to establish and release adhesive interactions through cell surface receptors known as cell adhesion molecules (CAMs). Several types of CAMs have been described regulating different aspects of neurodevelopment. Whereas some of them mediate interactions with the extracellular matrix, others allow contact with additional cells. In this review, we will focus on the role of two important families of cell–cell adhesion molecules (C-CAMs), classi…

neocortical developmentOrganogenesisSynaptogenesisneuronsNeocortexReviewExtracellular matrixradial glia cellsaxon targetingCell surface receptorNectinmedicineAnimalsHumansCAMslcsh:QH301-705.5nectinsMammalsneuronal migrationsynaptogenesisNeocortexCell adhesion moleculeChemistryCadherinneurodevelopmental disordersclassical cadherinsGeneral MedicineCorticogenesismedicine.anatomical_structurelcsh:Biology (General)SynapsesCell Adhesion MoleculesNeuroscienceCells
researchProduct

General approaches of processes involved in neurodegeneration using protein and printed phospholipids models

2023

neurodegenerationphospholipids modelprotein aggregationSettore CHIM/02 - Chimica Fisica
researchProduct

SENSING OF AMYLOID AGGREGATION USING A NOVEL BIS-THIOPHENE FLUORESCENT DYE

2012

neurodegenerative diseaseamyloid aggregationfluorescent probeAlzheimer's disease
researchProduct

Polymer Drug Conjugates for the Treatment of Neurodegenerative Disorders

2013

Nanociencia y nanotecnología son la base de técnicas innovadoras para el transporte de fármacos con beneficios potenciales para el paciente y nuevos mercados para la industria. La obtención de nuevos sistemas de transporte de fármacos más efectivos es uno de los principales retos actuales, junto con la mejora del diagnóstico tanto in vitro como in vivo y el desarrollo de tecnologías para la ingeniería tisular y la medicina regenerativa. Además de ser necesario disponer de moléculas con actividad farmacológica para conseguir terapias efectivas se necesitan su transporte y liberación controlada para llegar a conseguir tratamientos con mayor índice terapéutico. El uso de estrategias de direcci…

neurodegenerative disordersenfermedades neurodegenerativaspolymer therapeuticspolymer conjugatesconjugados poliméricospolímeros terapéuticos
researchProduct

Cranio-Facial Characteristics in Children with Autism Spectrum Disorders (ASD)

2019

Background: Cranio-facial anomalies frequently occur in neurodevelopmental disorders because both face and brain are derived from neuroectoderm. The identification of differences in the facial phenotype of children with Autism Spectrum Disorders (ASD) may reflect alterations in embryologic brain development in children with ASD. Methods: we evaluated 33 caucasian children with ASD using a 2D computerized photogrammetry. Anthropometric euclidean measurements and landmarks located on the soft tissue of the face and head, were based on five cranio-facial indexes. Relationships between anthropometric z-scores and participant characteristics (i.e., age, Global IQ, severity of autistic symptoms m…

neurodevelopmentautism spectrum disordersmental disordersmorphologylcsh:Rlcsh:Medicineautism spectrum disorderArticleSettore MED/39 - Neuropsichiatria InfantileJournal of Clinical Medicine
researchProduct

Editorial: Unawareness of Illness in Neurological Disorders: A Focussed Neurocognitive Approach Shedding Light on Neuropsychological Deficits and Neu…

2020

neuroimagingtheoretical modelsassessmentassessment; electrophysiological techniques; executive dysfunction; illness unawareness; neurodegenerative and vascular brain injuries; neuroimaging; theoretical modelslcsh:BF1-990neurodegenerative and vascular brain injuriesMEDLINETheoretical modelsNeuropsychologyexecutive dysfunctionillness unawarenesselectrophysiological techniqueslcsh:PsychologyEditorialNeuroimagingPsychologyPsychologyAssociation (psychology)NeurocognitiveGeneral PsychologyExecutive dysfunctionClinical psychologyFrontiers in psychology
researchProduct

Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms

2007

In the present work we reviewed recent advances concerning neuroprotective/neurotrophic effects of acute or chronic nicotine exposure, and the signalling pathways mediating these effects, including mechanisms implicated in nicotine addiction and nAChR desensitization. Experimental and clinical data largely indicate long-lasting effects of nicotine and nicotinic agonists that imply a neuroprotective/neurotrophic role of nAChR activation, involving mainly alpha 7 and alpha 4 beta 2 nAChR subtypes, as evidenced using selective nAChR agonists. Compounds interacting with neuronal nAChRs have the potential to be neuroprotective and treatment with nAChR agonists elicits long-lasting neurotrophic e…

neuroplasticitydesensitizationFGF-2nAChRReceptors NicotinicBiologyPharmacologySettore BIO/09 - FisiologiaNeuroprotectionNicotineNeurotrophic factorsmedicineAnimalsHumansnicotinic agonistNerve Growth FactorsNicotinic Agonistsneurotrophic factorBiological PsychiatryNeuronal PlasticitynAChR; nicotinic agonists; neurotrophic factors; FGF-2; neuroprotection; neurotrophism; addiction; desensitization; neuroplasticityBrainNeurodegenerative DiseasesTobacco Use DisorderPsychiatry and Mental healthNeuroprotective AgentsNerve growth factorNicotinic agonistNeurologySynaptic plasticityneurotrophismbiology.proteinneuroprotectionaddictionNeurology (clinical)Signal transductionNeuroscienceSignal Transductionmedicine.drugNeurotrophinJournal of Neural Transmission
researchProduct